Erythromycin Estolate

For research use only. Not for therapeutic Use.

  • CAT Number: R000101
  • CAS Number: 3521-62-8
  • Molecular Formula: C40H71NO14 C12H26SO4
  • Molecular Weight: 1056.39
  • Purity: ≥95%
Inquiry Now

Erythromycin Estolate(Cat No.:R000101)is a macrolide antibiotic used primarily in the treatment of bacterial infections, including respiratory tract, skin, and soft tissue infections. It is a prodrug of erythromycin, with improved absorption and bioavailability. Erythromycin Estolate works by inhibiting bacterial protein synthesis, thereby preventing bacterial growth. It is effective against a wide range of Gram-positive and some Gram-negative bacteria. Typically, it is used when patients are allergic to penicillin or in cases where other antibiotics are not effective. As with other macrolides, it may interact with certain medications and cause side effects.


Catalog Number R000101
CAS Number 3521-62-8
Synonyms

Erythromycin 2’-propanoate Dodecyl Sulfate Salt

Molecular Formula C40H71NO14 C12H26SO4
Purity ≥95%
Target Bacterial
Storage -20°C
IUPAC Name [(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyloxan-3-yl] propanoate;dodecyl hydrogen sulfate
InChI InChI=1S/C40H71NO14.C12H26O4S/c1-15-27-40(11,48)33(44)22(5)30(43)20(3)18-38(9,47)35(55-37-32(53-28(42)16-2)26(41(12)13)17-21(4)50-37)23(6)31(24(7)36(46)52-27)54-29-19-39(10,49-14)34(45)25(8)51-29;1-2-3-4-5-6-7-8-9-10-11-12-16-17(13,14)15/h20-27,29,31-35,37,44-45,47-48H,15-19H2,1-14H3;2-12H2,1H3,(H,13,14,15)/t20-,21-,22+,23+,24-,25+,26+,27-,29+,31+,32-,33-,34+,35-,37+,38-,39-,40-;/m1./s1
InChIKey AWMFUEJKWXESNL-JZBHMOKNSA-N
SMILES CCCCCCCCCCCCOS(=O)(=O)O.CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)OC(=O)CC)(C)O)C)C)O)(C)O
Reference

<p>Lovmar, Martin, and Tanel Tenson. /The Mechanism of Action of Macrolides, Lincosamides and Streptogramin B Reveals the Nascent Peptide Exit Path in the Ribosome./<em>Journal of Molecular Microbiology</em> 330.5 (2003): 1005-014.</p></span></p>

Request a Quote